A review of pharmacological treatments used in experimental models of traumatic brain injury (Q36799413)

16 August 2017

1 reference

title

A review of pharmacological treatments used in experimental models of traumatic brain injury (English)

1 reference

16 August 2017

traumatic brain injury

0 references

author name string

Olga N Kokiko

series ordinal

1

1 reference

PubMed ID

17453754

16 August 2017

Robert J Hamm

series ordinal

2

1 reference

16 August 2017

1 March 2007

1 reference

16 August 2017

1 reference

16 August 2017

21

1 reference

16 August 2017

3

1 reference

16 August 2017

259-274

1 reference

Pathophysiologic aspects of major depression following traumatic brain injury

16 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

Neuropharmacological modulation of cognitive deficits after brain damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

Cognitive outcome in traumatic brain injury survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

Learning and forgetting during posttraumatic amnesia in head injured patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

Massive increases in extracellular potassium and the indiscriminate release of glutamate following concussive brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

Novel pharmacologic therapies in the treatment of experimental traumatic brain injury: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

Dynamic changes in local cerebral glucose utilization following cerebral concussion in rats: evidence of a hyper- and subsequent hypometabolic state

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

Widespread and lateralization effects of acute traumatic brain injury on norepinephrine turnover in the rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

Cognitive impairment following traumatic brain injury: the effect of pre- and post-injury administration of scopolamine and MK-801.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

Effect of tetrahydroaminoacridine, a cholinesterase inhibitor, on cognitive performance following experimental brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

Effects of fluoxetine on the 5-HT1A receptor and recovery of cognitive function after traumatic brain injury in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

Effects of CDP-choline on the recovery of patients with head injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

Subacute methylphenidate treatment for moderate to moderately severe traumatic brain injury: a preliminary double-blind placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

Twenty years of pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

Working memory deficits after traumatic brain injury: catecholaminergic mechanisms and prospects for treatment -- a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

Amantadine for traumatic brain injury: does it improve cognition and reduce agitation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

The combined use of amantadine and l-dopa/carbidopa in the treatment of chronic brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

Effects of dopaminergic combination therapy for frontal lobe dysfunction in traumatic brain injury rehabilitation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

Procholinergic and memory enhancing properties of the selective norepinephrine uptake inhibitor atomoxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

Atomoxetine for individuals with traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

The combined intervention of therapy and bromocriptine mesylate to improve functional performance after brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

Motivational deficits after brain injury: effects of bromocriptine in 11 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

Attenuation of working memory and spatial acquisition deficits after a delayed and chronic bromocriptine treatment regimen in rats subjected to traumatic brain injury by controlled cortical impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

Depression following traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

Regulation of monoamine transporters: influence of psychostimulants and therapeutic antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

Methotrimeprazine in the treatment of agitation in acquired brain injury patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

Haloperidol, but Not Olanzapine, Impairs Cognitive Performance After Traumatic Brain Injury in Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

Selegiline enhances NGF synthesis and protects central nervous system neurons from excitotoxic and ischemic damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

Effect of low-dose treatment with selegiline on dopamine transporter (DAT) expression and amphetamine-induced dopamine release in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

The systemic administration of tacrine or selegiline facilitate spatial learning in aged fisher 344 rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

Preclinical evidence for neuroprotection with monoamine oxidase-B inhibitors in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

Postinjury administration of L-deprenyl improves cognitive function and enhances neuroplasticity after traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

Methylphenidate: a review of its neuropharmacological, neuropsychological and adverse clinical effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

Chronic methylphenidate treatment enhances water maze performance following traumatic brain injury in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

Chronic effects of traumatic brain injury on hippocampal vesicular acetylcholine transporter and M2 muscarinic receptor protein in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

Increased anticholinergic sensitivity following closed skull impact and controlled cortical impact traumatic brain injury in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

Fluid percussion injury causes loss of forebrain choline acetyltransferase and nerve growth factor receptor immunoreactive cells in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

Loss of forebrain cholinergic neurons following fluid-percussion injury: implications for cognitive impairment in closed head injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

Biochemical and behavioral evidence for muscarinic autoreceptors in the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

Binding sites for [3H]AF-DX 116 and effect of AF-DX 116 on endogenous acetylcholine release from rat brain slices

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

Rat hippocampal muscarinic autoreceptors are similar to the M2 (cardiac) subtype: comparison with hippocampal M1, atrial M2 and ileal M3 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

Post-injury administration of BIBN 99, a selective muscarinic M2 receptor antagonist, improves cognitive performance following traumatic brain injury in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

Effects of CDP-choline treatment on neurobehavioral deficits after TBI and on hippocampal and neocortical acetylcholine release.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

Chronic administration of a partial muscarinic M1 receptor agonist attenuates decreases in forebrain choline acetyltransferase immunoreactivity following experimental brain trauma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

Chronic intermittent nicotine administration attenuates traumatic brain injury-induced cognitive dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

Clinical use of cholinomimetic agents: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

Seizures and recovery from experimental brain damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

The effect of postinjury kindled seizures on cognitive performance of traumatically brain-injured rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

MDL 26,479: a potential cognition enhancer with benzodiazepine inverse agonist-like properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

Interactions between the effects of basal forebrain lesions and chronic treatment with MDL 26,479 on learning and markers of cholinergic transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

Enhancement of working memory performance in the rat by MDL 26,479, a novel compound with activity at the GABAA receptor complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

Chronic postinjury administration of MDL 26,479 (Suritozole), a negative modulator at the GABAA receptor, and cognitive impairment in rats following traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

Dynamic changes in N-methyl-D-aspartate receptors after closed head injury in mice: Implications for treatment of neurological and cognitive deficits

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

D-cycloserine reverses the working memory impairment of hippocampal-lesioned rats in a spatial learning task

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

Chronic, post-injury administration of D-cycloserine, an NMDA partial agonist, enhances cognitive performance following experimental brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

Delayed, post-injury treatment with aniracetam improves cognitive performance after traumatic brain injury in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

The nootropic compound BMY-21502 improves spatial learning ability in brain injured rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

Neuroprotective and neurotrophic actions of the mood stabilizer lithium: can it be used to treat neurodegenerative diseases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

Interactions between oxiracetam, aniracetam and scopolamine on behavior and brain acetylcholine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

Oxiracetam increases the release of endogenous glutamate from depolarized rat hippocampal slices.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

Nefiracetam improves Morris water maze performance following traumatic brain injury in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

Cognitive effects of antipsychotic agents in persons with traumatic brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

Effects of methylphenidate on attention deficits after traumatic brain injury: a multidimensional, randomized, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

Effects of single-dose methylphenidate on cognitive performance in patients with traumatic brain injury: a double-blind placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

Neurobehavioral effects of amantadine after pediatric traumatic brain injury: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

Effects of the dopaminergic agent and NMDA receptor antagonist amantadine on cognitive function, cerebral glucose metabolism and D2 receptor availability in chronic traumatic brain injury: a study using positron emission tomography (PET).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

Fluoxetine's effects on cognitive performance in patients with traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

Axis I and II psychiatric disorders after traumatic brain injury: a 30-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02699050701209964

10.1080/02699050701209964

21 January 2018

Identifiers

DOI

1 reference

release_6dib6545rfaalgc2mozamxkd4e

16 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6dib6545rfaalgc2mozamxkd4e

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

17453754

1 reference

PubMed ID

17453754